| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| Americas | Region | 2025 | USD | 2,806.0 | 40.4% |
| Asia Pacific | Region | 2025 | USD | 2,219.0 | 31.9% |
| Europe | Region | 2025 | USD | 1,923.0 | 27.7% |
| Americas | Region | 2024 | USD | 2,573.0 | 39.5% |
| Asia Pacific | Region | 2024 | USD | 2,167.0 | 33.3% |
| Europe | Region | 2024 | USD | 1,770.0 | 27.2% |
| Americas | Region | 2023 | USD | 2,732.0 | 40.0% |
| Asia Pacific | Region | 2023 | USD | 2,347.0 | 34.4% |
| Europe | Region | 2023 | USD | 1,754.0 | 25.7% |
| Americas | Region | 2022 | USD | 2,682.0 | 39.2% |
| Asia Pacific | Region | 2022 | USD | 2,467.0 | 36.0% |
| Europe | Region | 2022 | USD | 1,699.0 | 24.8% |
| Americas | Region | 2021 | USD | 2,404.0 | 38.0% |
| Asia Pacific | Region | 2021 | USD | 2,227.0 | 35.2% |
| Europe | Region | 2021 | USD | 1,688.0 | 26.7% |
| Americas | Region | 2020 | USD | 1,968.0 | 36.9% |
| Asia Pacific | Region | 2020 | USD | 1,928.0 | 36.1% |
| Europe | Region | 2020 | USD | 1,443.0 | 27.0% |
| Agilent CrossLab | Product | 2025 | USD | 2,908.0 | 41.9% |
| Life Sciences and Applied Markets | Product | 2025 | USD | 2,726.0 | 39.2% |
| Applied Markets | Product | 2025 | USD | 1,314.0 | 18.9% |
| Life Sciences and Applied Markets | Product | 2024 | USD | 3,215.0 | 49.4% |
| Diagnostics and Genomics | Product | 2024 | USD | 1,651.0 | 25.4% |
| Agilent CrossLab | Product | 2024 | USD | 1,644.0 | 25.3% |
| Life Sciences and Applied Markets | Product | 2023 | USD | 3,856.0 | 56.4% |
| Agilent CrossLab | Product | 2023 | USD | 1,568.0 | 23.0% |
| Diagnostics and Genomics | Product | 2023 | USD | 1,409.0 | 20.6% |
| Life Sciences and Applied Markets | Product | 2022 | USD | 4,007.0 | 58.5% |
| Agilent CrossLab | Product | 2022 | USD | 1,452.0 | 21.2% |
| Diagnostics and Genomics | Product | 2022 | USD | 1,389.0 | 20.3% |
| Life Sciences and Applied Markets | Product | 2021 | USD | 2,823.0 | 44.7% |
| Agilent CrossLab | Product | 2021 | USD | 2,200.0 | 34.8% |
| Diagnostics and Genomics | Product | 2021 | USD | 1,296.0 | 20.5% |
| Life Sciences and Applied Markets | Product | 2020 | USD | 2,392.0 | 44.8% |
| Agilent CrossLab | Product | 2020 | USD | 1,900.0 | 35.6% |
| Diagnostics and Genomics | Product | 2020 | USD | 1,047.0 | 19.6% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
